Fandom

VroniPlag Wiki

Shg/Fragment 054 01

< Shg

31.371Seiten in
diesem Wiki
Seite hinzufügen
Diskussion0 Teilen

Störung durch Adblocker erkannt!


Wikia ist eine gebührenfreie Seite, die sich durch Werbung finanziert. Benutzer, die Adblocker einsetzen, haben eine modifizierte Ansicht der Seite.

Wikia ist nicht verfügbar, wenn du weitere Modifikationen in dem Adblocker-Programm gemacht hast. Wenn du sie entfernst, dann wird die Seite ohne Probleme geladen.


Typus
BauernOpfer
Bearbeiter
SleepyHollow02
Gesichtet
No.png
Untersuchte Arbeit:
Seite: 54, Zeilen: 1 ff.
Quelle: Gu et al 2009
Seite(n): 0, Zeilen: 0
Figure 9: In vivo testosterone-HSA effects on tumor incidence in BALB/c mice

A) Arithmetic means ± SEM of colonic tumor incidence in BALB/c mice. Following treatment with the carcinogenic drug 1,2 dimethylhydrozine followed by dextrane sodium sulphate, one group (7 animals) was treated subcutaneously (3 times/week for 12 weeks) with 5mg/kg testosterone-HAS (black bar), whereas the other group (5 animals) remained untreated (white bar). # indicates significant difference between both groups (# P<0.01). B) After treatment, the colonic cancer tissue was cut to 8 μm frozen sections and fragmented DNA was assessed using TUNEL assay according to the manufacturer's instructions. Confocal laser scanning microscopy analyzed samples. Magnification, ×100. To further establish the in vivo role of mAR activation in mice model, in a second series of experiments APC mice have been used. In these experiments, animals were divided in two groups comprising 6 and 4 animals. One group (6 animals) was treated subcutaneously (3 times/week, for 8 weeks) with 5mg/kg testosterone-HSA, whereas the other group (4 animals) remained untreated. As shown in Fig. 10A, testosterone-HSA treatment resulted in a significant reduction of the tumor incidence by 80%. The histological analysis of tumors by TUNEL assay confirmed that apoptotic cells were present in appreciable numbers predominantly in the tumors of animals treated with testosterone-HSA (Fig. 10B, left panels) whereas they were significantly less abundant in the non-treated animals (Fig. 10B, right panels).

The animals used for these studies were divided in two groups comprising of 5 and 7 animals respectively. One group (7 animals) was treated subcutaneously (3 times/week for 12 weeks) with 5 mg/kg testosterone- HSA, whereas the other group (5 animals) remained untreated. The results (Fig. 7C) show that testosterone- HSA treatment produced a clear and significant reduction of tumor incidence by 65%. The histological analysis of tumors by TUNEL assay confirmed that apoptotic cells were present in significant numbers predominantly in the tumors of animals treated with testosterone- HSA (Fig. 7D, middle panels), while they were significantly less either in the non-treated animals (Fig. 7D, right panels), or in healthy tissues of treated animals (Fig. 7D, left panels)

Arithmetic means ± SEM of colonic tumor incidence in BALB/c mice. Following treatment with the carcinogenic drug 1, 2- dimethylhydrazine followed by dextrane sodium sulphate, one group (7 animals) was treated subcutaneously (3 times/week for 12 weeks) with 5 mg/kg testosterone-HAS (black bar), whereas the other group (5 animals) remained untreated (white bar). # indicates significant difference between both groups (# P < 0.01). (D) After treatment, the colonic cancer and healthy tissue was cut to 8 μm frozen sections and fragmented DNA was assessed by TUNEL assay according to the manufacturer's instructions. Confocal laser scanning microscopy analyzed samples. Magnification, ×100.

Anmerkungen
Sichter
(SleepyHollow02)

Auch bei Fandom

Zufälliges Wiki